Suppr超能文献

一种新的凝集素结合胆汁蛋白亚群可与胆固醇晶体结合,改变晶体形态,并抑制胆固醇结晶。

A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization.

作者信息

Busch N, Lammert F, Marschall H U, Matern S

机构信息

Department of Internal Medicine III, Aachen University of Technology, Germany.

出版信息

J Clin Invest. 1995 Dec;96(6):3009-15. doi: 10.1172/JCI118374.

Abstract

Biliary proteins inhibiting or promoting cholesterol crystallization are assumed to play a major role in cholesterol gallstone pathogenesis. We now report a new group of biliary proteins that bind to cholesterol crystals, modify crystal morphology, and inhibit cholesterol crystallization. Various glycoprotein mixtures were extracted from abnormal human gallbladder bile using lectin affinity chromatography on concanavalin A, lentil, and Helix pomatia columns and were added to supersaturated model bile. Independent of the protein mixtures added, from the cholesterol crystals harvested, the same four GPs were isolated having molecular masses of 16, 28, 63, and 74 kD, respectively. Each protein was purified using preparative SDS-PAGE, and influence on cholesterol crystallization in model bile was tested at 10 microg/ml. Crystal growth was reduced by 76% (GP63), 65% (GP16), 55% (GP74), and 40% (GP28), respectively. Thus, these glycoproteins are the most potent biliary inhibitors of cholesterol crystallization known so far. Evidence that the inhibiting effect on cholesterol crystallization is mediated via protein-crystal interaction was further provided from scanning electron microscopy studies. Crystals grown in presence of inhibiting proteins showed significantly more ordered structures. Incidence of triclinic crystals and regular aggregates was shifted from 30 to 70% compared with controls. These observations may have important implications for understanding the role of biliary proteins in cholesterol crystallization and gallstone pathogenesis.

摘要

抑制或促进胆固醇结晶的胆汁蛋白被认为在胆固醇胆结石的发病机制中起主要作用。我们现在报告一组新的胆汁蛋白,它们能与胆固醇晶体结合,改变晶体形态,并抑制胆固醇结晶。使用伴刀豆球蛋白A、扁豆和蜗牛凝集素亲和色谱法从异常人胆囊胆汁中提取各种糖蛋白混合物,并将其添加到过饱和模型胆汁中。无论添加何种蛋白质混合物,从收获的胆固醇晶体中分离出的都是相同的四种糖蛋白,其分子量分别为16、28、63和74kD。每种蛋白质都通过制备性SDS-PAGE进行纯化,并在10μg/ml的浓度下测试其对模型胆汁中胆固醇结晶的影响。晶体生长分别减少了76%(GP63)、65%(GP16)、55%(GP74)和40%(GP28)。因此,这些糖蛋白是迄今为止已知的最有效的胆汁胆固醇结晶抑制剂。扫描电子显微镜研究进一步提供了证据,表明对胆固醇结晶的抑制作用是通过蛋白质-晶体相互作用介导的。在存在抑制性蛋白质的情况下生长的晶体显示出明显更有序的结构。与对照组相比,三斜晶体和规则聚集体的发生率从30%转变为70%。这些观察结果可能对理解胆汁蛋白在胆固醇结晶和胆结石发病机制中的作用具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc93/186014/4697a0698665/jcinvest00018-0476-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验